About OCUGEN OPCO INC
Approaching healthcare innovation with purpose and agility to deliver new breakthroughs for people facing disease.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Malvern, Pennsylvania
- Founded
- 2013
- Company type
- Public Company
- Company profile name
- Ocugen
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene therapies to address major blindness diseases and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation - forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to address significant unmet medical need for large patient populations through our gene-agnostic approach.
Specialties
- ophthalmology
- biopharmaceutical
- biotechnology
- therapeutics biologics
- rare diseases
- inherited retinal disorders
- and wet AMD
Company locations
263 Great Valley Pkwy, Malvern, Pennsylvania 19355, US
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
Business areas
- Health Care
- Biopharma
- Biotechnology
On LinkedIn
- Followers
- 19,458
- People linked to this company
- 135
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
429,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.